Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for biotechnology industry professionals · Friday, March 29, 2024 · 699,731,354 Articles · 3+ Million Readers

Global Neurotech Industry Report 2016-2017: Market Analysis and Strategic Investment Guide of the Global Neurological Disease and Psychiatric Illness Markets

Dublin, Aug. 23, 2017 (GLOBE NEWSWIRE) -- The "Neurotech Industry 2016-2017 Report: Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global Neurological Disease and Psychiatric Illness Markets" report from NeuroInsights has been added to Research and Markets' offering.

The Neurotechnology Industry 2016-2017Report is an expanded and updated 650 page report of brain and nervous system markets and treatments. It is the only publication to provide a comprehensive pipeline and market analysis to help investors, companies and entrepreneurs easily identify opportunities, understand the competitive landscape, determine risks and understand the dynamics of rapidly changing CNS markets.

The report includes detailed information on products in development globally for over 20 indications at 800 companies including Alzheimer's, addiction, ALS, anxiety, depressive disorders, epilepsy, migraine, mild cognitive impairment, Huntington's, multiple sclerosis, obesity, pain, Parkinson's, schizophrenia, age-related macular degeneration, sensory disorders, sleep disorders, traumatic brain injury and stroke.

Key Topics Covered:

1: Executive Summary

The Brain Industry Revealed
- Neuropharmaceuticals
- Cell Therapies
- Neurodevices
- Neurodiagnostics

Investment Risks and Opportunities
- Translating Neuroscience into Neurotech
- The Neurotech Market Opportunity

Key Industry Facts and Findings

2: Trends and Drivers

Converging Technology Drivers
- Crossing the Blood Brain Barrier
Demographic Drivers
- More People Living Longer
Social Drivers
- The Lifestyle Improvement Market
Economic Drivers
- Global Economic Burden of Brain-Related Illness
- Rising Health Care Costs
Research Funding
- US Government Research Funding
- Stem Cell Funding
- International Government Research Funding
- Foundations Focus on the Brain
Intellectual Property Trends
- Global Intellectual Property Protection
- Patent Expirations

Neurotech Merger and Acquisition Activity (2005-Q2,2016)

3: Neuropharmaceutical Sector

Neuropharmaceutical Sector Overview
- Trends in Neuropharmaceuticals

Neuropharmaceutical Partnering and Licensing
- Partnering and Licensing Personnel
- Partnering and Licensing Deals 2004-Q2,2016

Neurology Markets and Pipelines
- Alzheimer's Disease (AD)
- AAMI and MCI

- ALS
- Epilepsy and Seizure Disorders
- Huntington's disease
- Migraine
- Multiple Sclerosis
- Parkinson's Disease
- Sleep Disorders
- Restless Legs Syndrome
- Stroke
- Traumatic Brain Injury
Psychiatry Markets and Pipelines
- Addiction
- Anxiety Disorders
- Attention Disorders
- Depressive Disorders
- Bipolar Disorder
- Obesity
- Schizophrenia
- Cognitive Impairment Associated with Schizophrenia
Sensory Markets and Pipelines
- Pain
- Retinal Disorders

4: Stem Cells and Neuroregeneration

Defining Stem Cell Markets and Players
- Therapeutics
- Drug Discovery Tools
- Stem Cell Banking
Stem Cell Approaches
- Background
- The Science of Transplantion
- Controlling Immune Rejection and Infection
- Sources and Harvesting of Stem Cells
- Embronic Stem Cells
- Fetal Stem Cells
- Adult Stem Cells
- Stimulation of Endogenous Stem Cells
- Stem Cells Scientific Hurdles
Markets and Treatments in Development
- Alzheimer's Disease
- Amyotrophic Lateral Sclerosis (ALS)
- Hearing Loss
- Huntington's Disease (HD)
- Multiple Sclerosis (MS)
- Parkinson's Disease
- Retinal Disorders
- Spinal Cord Injury (SCI)
- Stroke
- Other CNS Diseases

5: Neurodevice Sector

Neurodevice Sector Overview
- Neurodevice Markets
- Regulatory Process in the US
- Regulatory Process in the EU
- Neurodevice Sector Trends
- Investment by Major Device companies
- Neurodevice M&A Activity (2005-Q2, 2016)

Neuroprosthetic Devices
- Cochlear Implants
- Retinal Implants
- Motor Prostheses and Brain Computer Interfaces

Neuromodulation Devices
- Neuromodulation Device Clinial Trials and Recent Approvals
- Deep Brain Stimulation
- Essential Tremor
- Parkinson's Disease
- Primary Dystonia
- Severe Obsessive Compulsive Disorder
- Treatment-Resistant Depression
- Epilepsy
- Traumatic Brain Injury and Stroke
- Transcranial Magnetic Stimulation (TMS)
- Alzheimer's
- Treatment Resistant Depression
- Migraine

- Transcranial Electrical Stimulation (TES)
- Transcranial Direct Current Stimulation (tDCS)

- Transcranial Alternating Current Stimulation (tACS)
- Transcranial Random Noise Stimulation (tRNS)
- Focused Ultrasonic Modulation

- Spinal Cord Stimulation (SCS)
- Chronic and Neuropathic Pain
- Spinal Cord Injury
- Vagus Nerve Stimulation (VNS)
- Epilepsy
- Treatment-Resistant Depression
- Obesity
- Peripheral Stimulation
- Assisted Breathing
- Epilepsy
- Fecal Incontinence
- Foot Drop
- Hypertension
- Migraine
- Neuropathic Pain
- Restless Legs Syndrome
- Sleep Apnea
- Stroke
- Urinary Conditions
- Gastric Modulation and Obesity

Neurosurgical devices
- Radiosurgical Devices
- Neurosurgical Navigation and Equipment
- Image Guided Navigation (IGN)
- Intraoperative Magnetic Resonance Imaging (iMRI)
- Automated Surgical Systems
- Brain Monitoring
- Temperature Control Systems
- Neurovascular Intervention
- Ischemic Stroke
- Catheters, Stents and Perfusion devices
- Retrieval and Protection devices
- Ultrasound Thrombolysis
- Hemorrhagic Stroke
- Coils
- Liquid Embolics
- Stents
Neurosoftware
- Attention Deficit Disorder
- Cognition and Aging
- Stress and Emotional Wellbeing
- Autism
- Addiction and Obesity
- Pain
- Schizophrenia

Therapeutic NeuroGaming

6: Neurodiagnostics Sector

Neurodiagnostic Sector Overview
- FDA Approval and Reimbursement of Diagnostics
Neuroimaging Technologies
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Nuclear Medicine Imaging (PET, SPECT)
- Electro-encephalography (EEG)
- Magneto-encephalography (MEG)
In Vitro Diagnostics
- In Vitro Diagnostics Regulatory Landscape
- Emerging Diagnostics for Alzheimer's Disease
- Emerging Diagnostics for TBI
- Genetic Testing and Pharmacogenomics
- Protein Biomarker Assays
- Pattern Recognition in Diagnostics
- Emerging Diagnostics for Psychiatry
- Emerging Diagnostics for Autism
Neuroinformatics
- Diagnostic Software

7: Private Neurotechnology Investment

Private Investment in Neurotechnology
- Venture Capital Investment Trends
- Neurotech Venture Capital Investment
- Investing in Neuropharmaceuticals
- Investing in Stem Cells and Neuroregeneration
- Investing in Neurodevices
- Investing in Neurodiagnostics
- Private Company Financings, 2015
- Top financings 2004-2015
- Leading Neurotech Investors
- Leading Venture Capital Firms

8: Public Neurotechnology Investment

Investing in Public Neurotech Companies
- Neurotech Stock Universe
Neurotech Initial Public Offerings
NeuroInsights Neurotech Index

9: Neurotechnology Research Centers

Leading Neurotechnology Research Centers
- University of California, San Francisco (UCSF)
- University of California, Los Angeles (UCLA)
- University of California, San Diego (UCSD)
- Harvard
- Stanford University
- Massachusetts Institute of Technology (MIT)
- Columbia University
- Washington University, St. Louis
- University College London (UCL)
- Karolinska Institutet, Stockholm
- RIKEN Brain Science Institute, Japan
Places to Watch
- National Brain Research Centre (NBRC), India
- Neurosciences Victoria, Australia (NSV)
- Univeristy of Helsinki, Finland

10: Leading Neurotechnology Regions

The Global Neurotech Economy
Nexus Ranking and Methodology
Established Neurotech Nexus
Emerging Neurotech Nexus
Nascent Neurotech Nexus
Conclusions and Policy Recommendations

11: Company Profiles

Neuropharmaceutical & Cell Therapy Companies: Private
Neuropharmaceutical & Cell Therapy Companies: Public
Neurodevice Companies: Private
Neurodevice Companies: Public
Neurodiagnostic Companies: Private
Neurodiagnostic Companies: Public

12: Index

For more information about this report visit https://www.researchandmarkets.com/research/d2vn7j/neurotech

Source: NeuroInsights

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

                    
                    
                    CONTACT: Research and Markets
                             Laura Wood, Senior Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                             U.S. Fax: 646-607-1907
                             Fax (outside U.S.): +353-1-481-1716
                             Related Topics: Diagnostics, Central Nervous System Drugs , Biopharmaceuticals , Stem Cells , Mental Health , Neurology Devices , Mental Disorders Drugs 
                    

Primary Logo

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release